CBD Life Sciences Inc.
CBDL
$0.0004
$0.000.00%
| 03/31/2024 | 03/31/2023 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 105.80K | 78.40K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 105.80K | 78.40K | -- |
| Cost of Revenue | -- | -- | 59.70K | 50.90K | -- |
| Gross Profit | -- | -- | 46.10K | 27.40K | -- |
| SG&A Expenses | -- | -- | 5.12M | 6.57M | -- |
| Depreciation & Amortization | -- | -- | 13.30K | -- | -- |
| Other Operating Expenses | -- | -- | 11.90K | 16.40K | -- |
| Total Operating Expenses | -- | -- | 5.20M | 6.64M | -- |
| Operating Income | -- | -- | -5.10M | -6.56M | -- |
| Income Before Tax | -- | -- | -5.10M | -6.56M | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -- | -5.10 | -6.56 | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -5.10M | -6.56M | -- |
| EBIT | -- | -- | -5.10M | -6.56M | -- |
| EBITDA | -- | -- | -272.00K | -- | -- |
| EPS Basic | -- | -- | -0.08 | -0.12 | -- |
| Normalized Basic EPS | -- | -- | -0.05 | -0.07 | -- |
| EPS Diluted | -- | -- | -0.08 | -0.12 | -- |
| Normalized Diluted EPS | -- | -- | -0.05 | -0.07 | -- |
| Average Basic Shares Outstanding | -- | -- | 406.75M | 312.06M | -- |
| Average Diluted Shares Outstanding | -- | -- | 406.75M | 312.06M | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
